A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy-Reference-Cited by-同舟云学术

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Published:2023-03-13 Issue:4 Volume:29 Page:906-916
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Stein-Thoeringer Christoph K.,Saini Neeraj Y.,Zamir Eli^ORCID,Blumenberg Viktoria^ORCID,Schubert Maria-Luisa,Mor Uria^ORCID,Fante Matthias A.,Schmidt Sabine,Hayase Eiko,Hayase Tomo,Rohrbach Roman^ORCID,Chang Chia-Chi,McDaniel Lauren,Flores Ivonne,Gaiser Rogier,Edinger Matthias,Wolff Daniel^ORCID,Heidenreich Martin,Strati Paolo,Nair Ranjit,Chihara Dai,Fayad Luis E.,Ahmed Sairah,Iyer Swaminathan P.,Steiner Raphael E.^ORCID,Jain Preetesh^ORCID,Nastoupil Loretta J.^ORCID,Westin Jason^ORCID,Arora Reetakshi,Wang Michael L.^ORCID,Turner Joel,Menges Meghan,Hidalgo-Vargas Melanie,Reid Kayla,Dreger Peter,Schmitt Anita,Müller-Tidow Carsten^ORCID,Locke Frederick L.^ORCID,Davila Marco L.,Champlin Richard E.,Flowers Christopher R.,Shpall Elizabeth J.,Poeck Hendrik,Neelapu Sattva S.^ORCID,Schmitt Michael^ORCID,Subklewe Marion,Jain Michael D.^ORCID,Jenq Robert R.^ORCID,Elinav Eran^ORCID

Funder

Mark Foundation Endeavor Award

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-023-02234-6.pdf

Reference50 articles.

1. Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97–103 (2018).

2. Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97 (2018).

3. Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104–108 (2018).